News & Events
Signify Research’s latest external press coverage, company news and updates on key industry events that our analysts are attending
AI Investment Shift
22nd May 2023 – Sanjay Parekh – Featured on theimagingwire.com VC investment in the AI medical imaging sector has shifted notably in the last couple years, says a new report from UK market intelligence firm Signify Research. The report offers a fascinating look at an industry where almost $5B has been raised since 2015. Total […]
Meet the Team at EuroAnaesthesia 2023
18th May 2023 – Kelly Patrick, Principal Analyst at Signify Research will be attending the EuroAnaesthesia 2023 event in June 2023.Euroanaesthesia is recognised worldwide as one of the most important and influential annual congresses in anaesthesiology and intensive care. With a history of over 5000 international participants from more than 100 countries and exhibitors, Euroanaesthesia […]
What VBC Providers Demand From Their IT Solutions
16th May 2023 – Rohinee Lal – Featured on hitconsultant.net Value-based care (VBC) is a healthcare delivery model that differs from traditional fee-for-service because rather than compensating providers based on the number of services provided, it ties the amount providers earn to the results they deliver for their patients. The quality of these healthcare services […]
Ambulatory Diagnostic Cardiology Market to Hit $3.3 Billion by 2026
15th May 2023 – Kelly Patrick – Featured on dicardiology.com The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 billion by 2026. With a CAGR of 14.4% over the forecast period, the global market for Long-term ECG will be driven by additional demand for remote services as patients […]
The rocky road to implementing CT lung cancer screening (auntminnie.com)
18th May 2023 – Matthew Watson – Featured on auntminnie.com Despite declining tobacco use, lung cancer remains the leading cause of cancer deaths globally, often evading detection until advanced stages. It is unsurprising, then, that interest in targeted lung screening (LCS) programs has risen markedly in recent decades. Landmark clinical studies, including the NLST and […]